Jean-Yves Courtial

Dassault Aviation reduces share capital through stock cancellation

The Board of Directors of Dassault Aviation has decided to reduce the company's share capital by cancelling 684,288 treasury shares held in registered form.

March 06, 2026 at 12:06 pm EST

Europlasma unveils new project for its Fonderie de Bretagne subsidiary

Europlasma has announced that its subsidiary Fonderie de Bretagne (FDB), which aims to diversify into the offshore wind sector, has initiated technical discussions with the Pennavel floating offshore wind project.

March 06, 2026 at 12:00 pm EST

Prodways Group to Sell Its Software Division

March 06, 2026 at 03:12 am EST

Medincell Raises 48 Million Euros at 20.35 EUR per Share

The company announced that American and European healthcare-focused investors such as Perceptive Advisors, Kurma Growth Opportunities Fund, Affinity Asset Advisors, and Polar Capital participated in the transaction alongside the company's main historical shareholders.

March 06, 2026 at 02:53 am EST

The Calendar Weighs on Getlink Traffic

March 06, 2026 at 02:39 am EST

Medincell Unveils Private Placement

Medincell has announced the launch of a private placement representing approximately 6% of its share capital, through an offering to international institutional investors.

March 05, 2026 at 11:56 am EST

Jefferies Remains Positive on Medincell Despite Lowered Price Target

Following a strong 5.54% gain the previous day, Medincell shares have pulled back slightly (-0.76%, to 23.44 euros). Analysts at Jefferies still see potential in the stock, but have reduced their price target from 50 to 43 euros, while maintaining their buy recommendation.

March 05, 2026 at 05:41 am EST

Galderma: stock up after 2025 results and 2026 targets

Galderma shares are in particularly strong demand on the Zurich stock exchange (+6.80%, at 154.65 Swiss francs) today. The specialist in dermatological treatments and skin-care products posted strong full-year results and attractive prospects for 2026.

March 05, 2026 at 05:31 am EST

Europe Hesitates After Yesterday's Technical Rebound

Following a rally on European markets yesterday, which came after two sharp declines, indices are now back in positive territory after starting the day lower. Around 10:30 a.m., the CAC 40, which last night posted a year-to-date gain of just 0.22%, is up 0.29%, at 8,191.40.

March 05, 2026 at 04:39 am EST

Capgemini Secures McDonald's Loyalty for Five More Years

Capgemini has announced the extension of its partnership with McDonald's Corporation for an additional five years.

March 05, 2026 at 02:58 am EST

Bigben Secures Opening of Conciliation Proceedings

Bigben Interactive has announced that it has secured the opening of conciliation proceedings from the President of the Lille Métropole Commercial Court.

March 04, 2026 at 12:12 pm EST

Technical Rebound on European Markets

After two sessions of sharp declines, European indices managed to catch their breath. The CAC 40, which had notably fallen by 6% over three sessions—including a 5.56% drop in just two days with the onset of the war in Iran—rebounded by 0.79% to close at 8,167.73 points. However, France's main index has lost most of the gains recorded since the start of the year and has moved away from its all-time closing high reached last Thursday at 8,620.93 points.

March 04, 2026 at 11:57 am EST

Moderna to pay $950m to end litigation

Moderna has announced the resolution of its dispute with Arbutus Biopharma Corporation and Genevant Sciences GmbH.

March 04, 2026 at 08:35 am EST

Nexans Rebounds on Barclays Optimism

Nexans is among the top performers on the SBF 120 this morning (+4.46%, at 121.90 euros), driven by Barclays' decision to upgrade the stock from neutral to overweight and to significantly raise its price target from 132 to 157 euros. The previous day, the stock had fallen by 4.81%.

March 04, 2026 at 04:27 am EST

Euroapi Unveils Results and Outlook

In the 2025 fiscal year, Euroapi's revenues declined by 7% to €848.2 million, while EBITDA saw a significant improvement, rising from -€43.6 million to +€9.9 million. This strong performance is all the more impressive considering it includes €58.8 million in non-recurring charges related to the Focus 2027 plan.

March 03, 2026 at 12:27 pm EST

Planisware Launches Share Buyback Program

The company, specialized in AI-based B2B SaaS platforms for the Project Economy sector, is set to repurchase its own shares by December 19 for a maximum amount of 10 million euros. The acquired shares are intended to be cancelled.

March 03, 2026 at 12:16 pm EST

Implanet's Swingo Range Approved in the United States

Implanet has received welcome news from the United States, where health authorities have approved its 3D-Swingo cage range.

March 03, 2026 at 12:01 pm EST

OSE Immunotherapeutics Falls Back After Strategic Refocus Despite Positive Oddo BHF Opinion

OSE Immunotherapeutics lost ground (-1.46%, at 4.188 euros) after announcing an acceleration of its strategic refocus around its main late-stage value creation drivers: Lusvertikimab and Tedopi.

March 03, 2026 at 09:42 am EST

Carbios in Turmoil

Carbios (-5.58%, at 8.465 euros) is losing ground, hit by reports published in La Lettre, which state that bailiffs arrived at the company's premises last Thursday.

March 03, 2026 at 06:12 am EST

Quadient Announces Changes to Strengthen Its Digital Automation Platform

The company, which develops software for invoice automation and mail management, has announced a strengthening of its position as a software leader, with its CEO now taking direct charge of the digital automation platform business.

March 03, 2026 at 02:57 am EST

OSE Immunotherapeutics Announces Strategic Changes

OSE Immunotherapeutics has unveiled a targeted realignment of its R&D portfolio, in line with the company's previously announced 2026-2028 strategic plan.

March 02, 2026 at 12:15 pm EST